Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

ACHV

Achieve Life Sciences (ACHV)

Achieve Life Sciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ACHV
DateHeureSourceTitreSymboleSociété
09/05/202422h08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACHVAchieve Life Sciences Inc
09/05/202422h01GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
07/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACHVAchieve Life Sciences Inc
06/05/202417h16GlobeNewswire Inc.Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal MedicineNASDAQ:ACHVAchieve Life Sciences Inc
25/04/202414h00GlobeNewswire Inc.Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024NASDAQ:ACHVAchieve Life Sciences Inc
11/04/202414h00GlobeNewswire Inc.Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 ConferenceNASDAQ:ACHVAchieve Life Sciences Inc
28/03/202421h01GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
20/03/202413h00GlobeNewswire Inc.Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual MeetingNASDAQ:ACHVAchieve Life Sciences Inc
14/03/202413h00GlobeNewswire Inc.Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024NASDAQ:ACHVAchieve Life Sciences Inc
06/03/202422h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
29/02/202422h41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACHVAchieve Life Sciences Inc
29/02/202422h16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACHVAchieve Life Sciences Inc
29/02/202414h01GlobeNewswire Inc.Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA SubmissionNASDAQ:ACHVAchieve Life Sciences Inc
29/02/202414h00GlobeNewswire Inc.Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:ACHVAchieve Life Sciences Inc
27/02/202421h32Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACHVAchieve Life Sciences Inc
09/11/202322h00GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
26/10/202314h00GlobeNewswire Inc.Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023NASDAQ:ACHVAchieve Life Sciences Inc
03/10/202314h00GlobeNewswire Inc.Achieve Life Sciences Announces Participation at Upcoming Investor ConferencesNASDAQ:ACHVAchieve Life Sciences Inc
11/09/202314h00GlobeNewswire Inc.Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual MeetingNASDAQ:ACHVAchieve Life Sciences Inc
14/08/202322h00GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
01/08/202314h00GlobeNewswire Inc.Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and WebcastNASDAQ:ACHVAchieve Life Sciences Inc
18/07/202314h00GlobeNewswire Inc.Achieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual MeetingNASDAQ:ACHVAchieve Life Sciences Inc
11/07/202317h23GlobeNewswire Inc.Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA)NASDAQ:ACHVAchieve Life Sciences Inc
26/06/202312h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACHVAchieve Life Sciences Inc
09/06/202322h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACHVAchieve Life Sciences Inc
09/06/202322h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACHVAchieve Life Sciences Inc
25/05/202322h07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACHVAchieve Life Sciences Inc
25/05/202315h00GlobeNewswire Inc.Achieve Life Sciences Announces Pricing of $16.5 Million Registered Direct OfferingNASDAQ:ACHVAchieve Life Sciences Inc
23/05/202312h00GlobeNewswire Inc.Achieve Life Sciences Reports Statistically Significant Smoking Cessation Benefit for Cytisinicline in Second, Confirmatory Phase 3 Clinical TrialNASDAQ:ACHVAchieve Life Sciences Inc
17/05/202314h00GlobeNewswire Inc.Achieve Life Sciences Announces Refinancing of Outstanding Loan with Silicon Valley BankNASDAQ:ACHVAchieve Life Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:ACHV